Wise Guy Reports
Wise Guy Reports press releases
-
Wind Power in Austria, Market Outlook to 2025, Update 2015 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company ProfilesSummary"Wind Power in Austria, Market Outlook to 2025, Update 2015 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles” is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the wind power market in...
-
The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in Q1 2015. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies.
-
The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in March 2015. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies.
-
The report provides detailed information on M&As, equity/debt offerings, private equity (PE), venture financing and partnership transactions recorded in the power industry in Q1 2015. The report portrays detailed comparative data on the number of deals and their value in the last five quarters, categorized into deal types, segments and geographies. The report also provides information on the top PE, venture capital (VC) and advisory firms in the power industry.
-
April 2015 saw a number of policy changes in the global renewable power market. In the Americas, New York, US pledged a sizeable investment in renewable projects, while Brazil auctioned renewable capacity for domestic use and negotiated with Bolivia over a hydropower project.
-
This report provides comprehensive information on the current therapeutic developmental pipeline of AC Immune SA’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
-
This report provides comprehensive information on the current therapeutic developmental pipeline of Intra-Cellular Therapies, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
-
This report provides comprehensive information on the current therapeutic developmental pipeline of Anergis SA’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
-
This report provides comprehensive information on the current therapeutic developmental pipeline of Ecrins Therapeutics SAS’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
-
This report provides comprehensive information on the current therapeutic developmental pipeline of Bioo Therapeutics’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
-
This report provides comprehensive information on the current therapeutic developmental pipeline of Jazz Pharmaceuticals plc’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
-
This report provides comprehensive information on the current therapeutic developmental pipeline of GW Pharmaceuticals plc’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
-
This report provides comprehensive information on the current therapeutic developmental pipeline of Avineuro Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
-
This report provides comprehensive information on the current therapeutic developmental pipeline of Rexahn Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
-
This report provides comprehensive information on the current therapeutic developmental pipeline of Chroma Therapeutics Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
-
This report provides comprehensive information on the current therapeutic developmental pipeline of Biovista Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
-
This report provides comprehensive information on the current therapeutic developmental pipeline of Orion Oyj’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
-
This report provides comprehensive information on the current therapeutic developmental pipeline of AVEO Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
-
This report provides comprehensive information on the current therapeutic developmental pipeline of Biomay AG’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
-
This report provides comprehensive information on the current therapeutic developmental pipeline of Charleston Laboratories, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
